Skip to main content
OpenTrials

Clinical trial condition

Purine-Pyrimidine Metabolism, Inborn Errors

Explore clinical trials studying Purine-Pyrimidine Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

266 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Purine-Pyrimidine Metabolism, Inborn Errors trial results

Completed

Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout

NCT05253833

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Arthrosi Investigative Site (410) Birmingham, Alabama, United States
  • Arthrosi Investigative Site (403) Phoenix, Arizona, United States
  • Arthrosi Investigative Site (416) Sun City, Arizona, United States
  • Arthrosi Investigative Site (417) Tucson, Arizona, United States
View Trial Details
Completed

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

NCT04772313

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +10 more
Locations
  • University of Alabama at Birmingham (UAB) - Center for Education & Research on Therapeutics of Musculoskeletal Disorders Birmingham, Alabama, United States
  • Arizona Arthritis and Rheumatology Associates Flagstaff, Arizona, United States
  • Arizona Arthritis and Rheumatology Associates Glendale, Arizona, United States
  • Arizona Arthritis and Rheumatology Associates Mesa, Arizona, United States
View all 15 locations
View Trial Details

Related conditions